S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMAMaria Cristina Pirosa, Davide Rossi, Gabriela Forestieri et al.|HemaSphere|2022Cited by 1
CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER IN CLASSIC HODGKIN LYMPHOMAValeria Spina, Davide Rossi, Maria Cristina Pirosa et al.|Hematological Oncology|2021Cited by 0
HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin LymphomaLodovico Terzi di Bergamo, Davide Rossi, Maria Cristina Pirosa et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0
Poster: HL-370 Fragmentome Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin LymphomaLodovico Terzi di Bergamo, Davide Rossi, Maria Cristina Pirosa et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 0